Physicians' Academy for Cardiovascular Education

A patient with elevated Lp(a): What is current clinical practice to manage this condition?

10' education - May 27, 2016 - Innsbruck, Germany - Prof. Klaus G. Parhofer, MD - University of Munich, Germany - FRIDAY, MAY 27, 2016, lunch symposium at Lp(a) symposium prior to EAS

Video navigation menu

  • Elevated Lp(a) levels as an independent and additive CV risk factor 0:41
  • When to treat a patient with elevated Lp(a)? 1:20
  • Currently available drugs to lower Lp(a) levels 2:07
  • Effect of lipoprotein apheresis on Lp(a) levels 5:32
  • Does lowering Lp(a) levels improve clinical outcomes? 6:21
  • How are patients currently treated - treatment algorithm 9:10


Prof. Klaus G. Parhofer, MD – is Professor of Endocrinology and Metabolism at the University of Munich in Germany.


The PACE foundation received funding for this session via an unrestricted educational grant from Amgen

View the slides of this presentation

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: